1 Day Range
Mkt Cap
Div Yield
Popular Today
Popular Today
Popular All Time
Charts and Videos
Charts and Videos

REGN Stock Chart




Price History
Average Volume (10 day) ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Price/Book Ratio, FY ---
Price/Sales Ratio, FY ---
Dividends Paid, FY ---
Dividends per Share, FY ---
Expected Annual Dividends ---
Dividends Yield ---
Net Margin, TTM ---
Gross Margin, TTM ---
Operating Margin, TTM ---
Pretax Margin, TTM ---
Balance Sheet
Current Ratio, FQ ---
Debt to Equity, FQ ---
Net Debt, FQ ---
Quick Ratio, FQ ---
Total Assets, FQ ---
Total Debt, FQ ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
Gross Profit, FY ---
Last Annual EPS ---
Last Annual Revenue, FY ---
Net Income, FY ---
Total Revenue, FY ---
Free Cash Flow, TTM ---
Operating Metrics
Return on Assets, TTM ---
Return on Equity, TTM ---
Return on Invested Capital, TTM ---
Revenue per Employee, TTM ---


ashwinpv9 ashwinpv9 REGN, 1D, Short ,
16 0 1
REGN, 1D Short
REGN Short

Short only below the support line

10 0 1

test regn

DevinBoyle55 DevinBoyle55 REGN, D, Long ,
159 0 3
REGN, D Long
$REGN 50d/200d Golden Cross

$REGN Regeneron Pharma - 50d/200d ema Golden Cross on the daily chart last week after a solid earnings report in early August. Assuming bullish trend line holds, expecting continued gains over the next couple months. Near term target - $391 (gap fill) Medium term target - $420

RocketTickers RocketTickers REGN, D, Long ,
18 0 2
REGN, D Long
FDA Approves EYLEA® (aflibercept) Injection sBLA

REGN: Regeneron Pharmaceuticals, Inc. 2018-08-17 07:00:00 FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration

RocketTickers RocketTickers REGN, D, Long ,
7 0 1
REGN, D Long
Regeneron and Teva Announce Positive Topline Phase 3

TEVA: Teva Pharmaceutical Industries Ltd. 2018-08-16 07:00:00 Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

Astatine Astatine REGN, 1D, Long ,
54 0 1
REGN, 1D Long
Really beautiful buying setup - REGN

Will wait patiently for REGN to get into the buying box -- expect it to arrive last august

ashwinpv9 ashwinpv9 REGN, 1D, Short ,
33 0 3
REGN, 1D Short
REGN Short Play - Negative Divergence and Fib resistance

REGN hitting some resistance here and negative divergence on the RSI. Inside bar with closed with a doji today.

48 0 1
REGN, 1D Long

- 1 YEAR Trend line breached

FX008 FX008 REGN, 1D, Long ,
46 0 2
REGN, 1D Long

It seems the stock is changing the trend and may have bottomed out. Please ignore my previous post as targets were not correct.

FX008 FX008 REGN, 1D, Long ,
36 0 1
REGN, 1D Long
REGN- possible change in the trend.

It seems the stock is changing the trend and may have bottomed out.

29 0 0
REGN, 1D Long
$REGN 1 Year Trend looks to break out Bullish - #REGN chart

$REGN 1 year trend line breakout likely. ER run price action lowers to ER. Sales figures are on "cusp of heating up". cheaper drugs for cholestorel.

viewtrades viewtrades REGN, 1D, Long ,
80 1 2
REGN, 1D Long
Ready for the next leg up. Indicators are here.

-Longterm downtrend broken -Bottom found -Bull flag formation followed by breakout -Breakout from overarching ascending wedge. ..... BULL SZN! here's the monthly look, the next leg is coming folks.

MDee MDee REGN, 1M, Long ,
38 0 1
REGN, 1M Long
REGN - time to run?

REGN broke out on daily w/ greater than avg. vol on Fri. Looking for a continuation this week. I'd like to see a close above 309.92 which could lead to a push towards 322.08, 327, 339

CarlosGragirena CarlosGragirena REGN, 240, Short ,
33 0 3
REGN, 240 Short
Downtrend line

Downtrendline from 502,01 to 291,77

14 0 1
REGN, 240
Downtrend line

Downtrend line. 502.01 to 291,77

matt.sulli42 matt.sulli42 REGN, 1W, Short ,
33 0 2
REGN, 1W Short
regn head and shoulders weekly

target is length of head from neckline

hesswg48 hesswg48 REGN, 1W, Long ,
47 0 0
REGN, 1W Long
REGN- Slowly Bleeding to Death.....CURE TO COME

Taking a quick look at the chart and analyzing volume, one can easily see the turnaround is soon to come. Look for a consistent price turnaround in the month of July (2018). The confirmed turnaround should occur early-mid August (2018). What do I know right???

Larster Larster REGN, 1D, Long ,
70 0 3
REGN, 1D Long
Opportunity in great pharma value

Correction looks done. Wait for smaller correction of last break out impulse and buy with both hands.

Show More Ideas 12345
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
HE עברית
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out